Page last updated: 2024-09-05

erlotinib hydrochloride and Vestibular Diseases

erlotinib hydrochloride has been researched along with Vestibular Diseases in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Halpin, C; Harris, GJ; McClatchey, AI; O'Donnell, CC; Plotkin, SR; Singh, MA	1

Other Studies

1 other study(ies) available for erlotinib hydrochloride and Vestibular Diseases

Article	Year
Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy. Nature clinical practice. Oncology, 2008, Volume: 5, Issue:8 Topics: Audiometry, Pure-Tone; Auditory Threshold; Cochlear Implantation; Combined Modality Therapy; Ear Neoplasms; Erlotinib Hydrochloride; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibromatosis 2; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome; Vestibular Diseases	2008

Article

Year

Audiologic and radiographic response of NF2-related vestibular schwannoma to erlotinib therapy.

Nature clinical practice. Oncology, 2008, Volume: 5, Issue:8

Topics: Audiometry, Pure-Tone; Auditory Threshold; Cochlear Implantation; Combined Modality Therapy; Ear Neoplasms; Erlotinib Hydrochloride; Hearing Loss, Sensorineural; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neurofibromatosis 2; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome; Vestibular Diseases

2008